ACROBiosystems Launches ACRO AIx and Rapid Antibody Validation Service

Sep 24, 2026
ACROBiosystems introduced ACRO AIx, a wet lab infrastructure for AI drug research, alongside a service that can return antibody affinity data within four days.

ACROBiosystems announced in a press release the launch of ACRO AIx and its CHO-Direct Rapid High Throughput Affinity Validation Service. CHO-Direct can provide antibody affinity data within four days of sequence submission, using a CHO cell system to test candidates generated through computational drug discovery.

ACRO AIx combines standardized products, experimental tools, validation modules and data connections for biopharmaceutical research. Its tools include CHO cell lines, culture media and transfection reagents, while planned APIs will connect inventory, product specifications, quality reports and order status with AI tools and research workflows.

The company says its validation capabilities cover more than 5,000 target proteins and over 300 membrane protein targets. It also introduced GlobalLifeShip, a service for international transportation, overseas warehousing and final delivery.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.